Verition Fund Management LLC Xencor Inc Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $2.41 Million - $3.14 Million	-70,229 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$40.81 - $53.88 $1.57 Million - $2.07 Million	38,493 Added 121.29%	70,229 $3.02 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $1.16 Million - $1.51 Million	31,736 New	31,736 $1.39 Million
Q1 2020 May 15, 2020	SELL	$20.69 - $37.79 $136,367 - $249,073	-6,591 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $215,855 - $273,065	6,591 New	6,591 $227,000

199

73.7M

1.7K

4.2K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $814M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.